Cardiovascular disease in hereditary haemophilia: The challenges of longevity.

"CONFLICT OF INTEREST Catherine Harrison has received conference support, educational speaker and/or consultancy fees from Roche, Sobi, Pfizer, Novo Nordisk, Takeda, CSL Behring, Sanofi. Sarah Mangles has received conference support, educational speaker fees and/or advisory board fees from SOBI, Roche, NovoNordisk, Takeda, CSL Behring and Octapharma. Susan Shapiro has received conference support, educational speaker fees, and/or advisory board fees from Pfizer, Bayer, Shire, Takeda, Roche and CSL Behring. Gary Benson, Gillian Evans and Mike Makris have no potential conflicts of interest in relation to this manuscript."

"The authors are members of the UK Haemophilia Centre Doctors Organisation (UKHCDO) Co‐Morbidity Working Party and would like to thank UKHCDO for funding an initial literature search by the Oxford NHS Blood and Transplant (NHSBT) team. Susan Shapiro receives funding support from the Medical Research Council (MR/T024054/1). The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health."